2025 Q4 -tulosraportti
Vain PDF
60 päivää sitten
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 147 | - | - | ||
| 1 000 | - | - | ||
| 450 | - | - | ||
| 400 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
·5 t sitten · MuokattuCircio included in three European STOXX indices Index provider STOXX has published the official changes for its subsector indices effective from June 22, 2026, as documented in the link. Circio Holdings (CRNA) is confirmed to be added to three different indices: STOXX Europe Total Market Biotechnology STOXX Europe Total Market Pharmaceuticals STOXX Europe Total Market Pharmaceuticals & Biotechnology What this means for the stock: Automatic buying pressure: Index funds and European ETFs that follow these specific indices are mechanically obliged to buy into the stock. This capital inflow usually occurs in the days just before or on the implementation day itself, June 22. Increased visibility: The inclusion increases exposure to institutional and foreign investors who filter their investments based on European sector indices. Recognition: It serves as an external confirmation that the company now satisfies the criteria to be considered an established biotech company in the European market. This is a structurally positive piece of news that provides predictable, passive buying pressure in the order book towards the end of the month. It is worth noting that the new warrant shares will be delivered to VPS accounts around June 19. Any potential short-term selling pressure from this delivery will therefore hit the market just before index funds must make their mechanical purchases on June 22. In short, the index inclusion is positive, but not revolutionary news in itself. It is not a game-changer alone, but it provides solid and predictable support in the order book. Combined with the fact that Proof of Concept (PoC) data from Big Pharma is likely just around the corner, everything is set for a very exciting period ahead. https://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Subsector_Indices_20260613.pdfhttps://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Sector_Indices_20260613.pdfhttps://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Industry_Indices_20260613.pdf
·7 t sittenMany refer to Warren Buffett when recommending broad diversification and index funds. At the same time, Buffett himself did not become a billionaire by buying the entire market – he became rich by making large, concentrated investments in companies he understood very well. Famous quotes: - The stock market is a mechanism for transferring money from the impatient to the patient. - Our favorite holding period is forever. - The big money is not in buying and selling, but in waiting. Buffett recommends index funds because most people don't have the time, knowledge, or discipline to beat the market. He didn't buy "everything". He made large, concentrated investments in a few companies he understood very well. He looked for investments where he could lose little if he was wrong, but earn a lot if he was right. He only bought when the price was significantly lower than what he believed the company was worth. He often waited a long time for the right opportunities and bet big when they came. The simplest way to describe Buffett is: "Don't bet on everything. Wait until you find something you truly understand, that is cheap enough, and where the upside is much greater than the downside." The core of his philosophy is that the biggest gains often come from owning good companies long enough for the compound interest effect to work, not from constantly jumping in and out of the market. How do you think Buffett would evaluate the case here :)
·9 t sittenONE DAY SOMEONE WILL ASK YOU WHY. 🏆 Why you held. Why you didn't sell when it was red. Why you sat still while others laughed. And you will tell them this: That you saw a small Norwegian company almost no one had heard of. That you dug. That you read every message, understood every study, checked every number — until you knew more than almost everyone else in the room. That you understood that circular RNA was not noise, but direction. That one of the world's five largest pharmaceutical companies used its own money to test the technology. That the man at the helm had done it before — built something real out of almost nothing. That everything pointed the same way, long before the crowd understood it. And that you — while others chased the next quick gain — chose to own something you actually believed in. And stayed. It's not luck that builds something that lasts. It's seeing clearly, early, and having enough backbone to stay when things fluctuate. Red days are forgotten. Conviction is remembered. One day they will ask why. And you just smile and say: "Because I did my homework. And because I knew what I owned." We know what we own. ♟️🧱🍷- ·9 t sittenEVERYONE IS COMPETING IN THE SAME POOL. CIRCIO SWIMS IN ITS OWN. 🏊🔵 Here's something almost no one understands about the competitive landscape. Yes — there are other circRNA companies. Orna was acquired by Lilly. There are more. But look CLOSELY at what they actually do. Almost everyone does the same thing: produces circular RNA in a factory, packages it in a lipid nanoparticle (LNP), and injects it. Same recipe. Same crowded pool. Everyone is fighting for the same tricks. Circio does something completely different. Instead of producing the RNA externally and delivering it — they deliver a genetic "recipe" via a vector (AAV/DNA), and let your cell produce the circular RNA itself. Over and over again. From within. It's not a better version of what others do. It's a different way in. And in exactly that lane, Circio describes itself as the pioneer — without a known direct competitor doing exactly the same thing. Think about it. While the entire field crowds into one pool, Circio has found an entire lane they swim in alone. It's not about being the best among many. It's about being the only one in its own field. We know what we own. ♟️🧱🍷
·11 t sitten · MuokattuI have decided that a portrait of Erik Wiklund and Thomas Hansen shall hang in a place of honor in my home when Circio delivers big time🏆 My descendants shall know why they have it the way they are going to get it. CIRCIO ❤️❤️ maybe @bennyz also gets to hang but then I need to get a better picture of him.
·9 t sittenI remember from the book about Zlatan that he had a picture of his dirty legs in the locker room after a match hanging on the wall. He was asked why he had such an ugly picture on the wall. He just replied dryly, "It is they who have paid for all this"
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
60 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·5 t sitten · MuokattuCircio included in three European STOXX indices Index provider STOXX has published the official changes for its subsector indices effective from June 22, 2026, as documented in the link. Circio Holdings (CRNA) is confirmed to be added to three different indices: STOXX Europe Total Market Biotechnology STOXX Europe Total Market Pharmaceuticals STOXX Europe Total Market Pharmaceuticals & Biotechnology What this means for the stock: Automatic buying pressure: Index funds and European ETFs that follow these specific indices are mechanically obliged to buy into the stock. This capital inflow usually occurs in the days just before or on the implementation day itself, June 22. Increased visibility: The inclusion increases exposure to institutional and foreign investors who filter their investments based on European sector indices. Recognition: It serves as an external confirmation that the company now satisfies the criteria to be considered an established biotech company in the European market. This is a structurally positive piece of news that provides predictable, passive buying pressure in the order book towards the end of the month. It is worth noting that the new warrant shares will be delivered to VPS accounts around June 19. Any potential short-term selling pressure from this delivery will therefore hit the market just before index funds must make their mechanical purchases on June 22. In short, the index inclusion is positive, but not revolutionary news in itself. It is not a game-changer alone, but it provides solid and predictable support in the order book. Combined with the fact that Proof of Concept (PoC) data from Big Pharma is likely just around the corner, everything is set for a very exciting period ahead. https://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Subsector_Indices_20260613.pdfhttps://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Sector_Indices_20260613.pdfhttps://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Industry_Indices_20260613.pdf
- ·7 t sittenMany refer to Warren Buffett when recommending broad diversification and index funds. At the same time, Buffett himself did not become a billionaire by buying the entire market – he became rich by making large, concentrated investments in companies he understood very well. Famous quotes: - The stock market is a mechanism for transferring money from the impatient to the patient. - Our favorite holding period is forever. - The big money is not in buying and selling, but in waiting. Buffett recommends index funds because most people don't have the time, knowledge, or discipline to beat the market. He didn't buy "everything". He made large, concentrated investments in a few companies he understood very well. He looked for investments where he could lose little if he was wrong, but earn a lot if he was right. He only bought when the price was significantly lower than what he believed the company was worth. He often waited a long time for the right opportunities and bet big when they came. The simplest way to describe Buffett is: "Don't bet on everything. Wait until you find something you truly understand, that is cheap enough, and where the upside is much greater than the downside." The core of his philosophy is that the biggest gains often come from owning good companies long enough for the compound interest effect to work, not from constantly jumping in and out of the market. How do you think Buffett would evaluate the case here :)
- ·9 t sittenONE DAY SOMEONE WILL ASK YOU WHY. 🏆 Why you held. Why you didn't sell when it was red. Why you sat still while others laughed. And you will tell them this: That you saw a small Norwegian company almost no one had heard of. That you dug. That you read every message, understood every study, checked every number — until you knew more than almost everyone else in the room. That you understood that circular RNA was not noise, but direction. That one of the world's five largest pharmaceutical companies used its own money to test the technology. That the man at the helm had done it before — built something real out of almost nothing. That everything pointed the same way, long before the crowd understood it. And that you — while others chased the next quick gain — chose to own something you actually believed in. And stayed. It's not luck that builds something that lasts. It's seeing clearly, early, and having enough backbone to stay when things fluctuate. Red days are forgotten. Conviction is remembered. One day they will ask why. And you just smile and say: "Because I did my homework. And because I knew what I owned." We know what we own. ♟️🧱🍷
- ·9 t sittenEVERYONE IS COMPETING IN THE SAME POOL. CIRCIO SWIMS IN ITS OWN. 🏊🔵 Here's something almost no one understands about the competitive landscape. Yes — there are other circRNA companies. Orna was acquired by Lilly. There are more. But look CLOSELY at what they actually do. Almost everyone does the same thing: produces circular RNA in a factory, packages it in a lipid nanoparticle (LNP), and injects it. Same recipe. Same crowded pool. Everyone is fighting for the same tricks. Circio does something completely different. Instead of producing the RNA externally and delivering it — they deliver a genetic "recipe" via a vector (AAV/DNA), and let your cell produce the circular RNA itself. Over and over again. From within. It's not a better version of what others do. It's a different way in. And in exactly that lane, Circio describes itself as the pioneer — without a known direct competitor doing exactly the same thing. Think about it. While the entire field crowds into one pool, Circio has found an entire lane they swim in alone. It's not about being the best among many. It's about being the only one in its own field. We know what we own. ♟️🧱🍷
- ·11 t sitten · MuokattuI have decided that a portrait of Erik Wiklund and Thomas Hansen shall hang in a place of honor in my home when Circio delivers big time🏆 My descendants shall know why they have it the way they are going to get it. CIRCIO ❤️❤️ maybe @bennyz also gets to hang but then I need to get a better picture of him.·9 t sittenI remember from the book about Zlatan that he had a picture of his dirty legs in the locker room after a match hanging on the wall. He was asked why he had such an ugly picture on the wall. He just replied dryly, "It is they who have paid for all this"
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 147 | - | - | ||
| 1 000 | - | - | ||
| 450 | - | - | ||
| 400 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
2025 Q4 -tulosraportti
Vain PDF
60 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·5 t sitten · MuokattuCircio included in three European STOXX indices Index provider STOXX has published the official changes for its subsector indices effective from June 22, 2026, as documented in the link. Circio Holdings (CRNA) is confirmed to be added to three different indices: STOXX Europe Total Market Biotechnology STOXX Europe Total Market Pharmaceuticals STOXX Europe Total Market Pharmaceuticals & Biotechnology What this means for the stock: Automatic buying pressure: Index funds and European ETFs that follow these specific indices are mechanically obliged to buy into the stock. This capital inflow usually occurs in the days just before or on the implementation day itself, June 22. Increased visibility: The inclusion increases exposure to institutional and foreign investors who filter their investments based on European sector indices. Recognition: It serves as an external confirmation that the company now satisfies the criteria to be considered an established biotech company in the European market. This is a structurally positive piece of news that provides predictable, passive buying pressure in the order book towards the end of the month. It is worth noting that the new warrant shares will be delivered to VPS accounts around June 19. Any potential short-term selling pressure from this delivery will therefore hit the market just before index funds must make their mechanical purchases on June 22. In short, the index inclusion is positive, but not revolutionary news in itself. It is not a game-changer alone, but it provides solid and predictable support in the order book. Combined with the fact that Proof of Concept (PoC) data from Big Pharma is likely just around the corner, everything is set for a very exciting period ahead. https://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Subsector_Indices_20260613.pdfhttps://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Sector_Indices_20260613.pdfhttps://www.stoxx.com/document/News/2026/June/STOXX_Components_Changes_STOXX_Industry_Indices_20260613.pdf
- ·7 t sittenMany refer to Warren Buffett when recommending broad diversification and index funds. At the same time, Buffett himself did not become a billionaire by buying the entire market – he became rich by making large, concentrated investments in companies he understood very well. Famous quotes: - The stock market is a mechanism for transferring money from the impatient to the patient. - Our favorite holding period is forever. - The big money is not in buying and selling, but in waiting. Buffett recommends index funds because most people don't have the time, knowledge, or discipline to beat the market. He didn't buy "everything". He made large, concentrated investments in a few companies he understood very well. He looked for investments where he could lose little if he was wrong, but earn a lot if he was right. He only bought when the price was significantly lower than what he believed the company was worth. He often waited a long time for the right opportunities and bet big when they came. The simplest way to describe Buffett is: "Don't bet on everything. Wait until you find something you truly understand, that is cheap enough, and where the upside is much greater than the downside." The core of his philosophy is that the biggest gains often come from owning good companies long enough for the compound interest effect to work, not from constantly jumping in and out of the market. How do you think Buffett would evaluate the case here :)
- ·9 t sittenONE DAY SOMEONE WILL ASK YOU WHY. 🏆 Why you held. Why you didn't sell when it was red. Why you sat still while others laughed. And you will tell them this: That you saw a small Norwegian company almost no one had heard of. That you dug. That you read every message, understood every study, checked every number — until you knew more than almost everyone else in the room. That you understood that circular RNA was not noise, but direction. That one of the world's five largest pharmaceutical companies used its own money to test the technology. That the man at the helm had done it before — built something real out of almost nothing. That everything pointed the same way, long before the crowd understood it. And that you — while others chased the next quick gain — chose to own something you actually believed in. And stayed. It's not luck that builds something that lasts. It's seeing clearly, early, and having enough backbone to stay when things fluctuate. Red days are forgotten. Conviction is remembered. One day they will ask why. And you just smile and say: "Because I did my homework. And because I knew what I owned." We know what we own. ♟️🧱🍷
- ·9 t sittenEVERYONE IS COMPETING IN THE SAME POOL. CIRCIO SWIMS IN ITS OWN. 🏊🔵 Here's something almost no one understands about the competitive landscape. Yes — there are other circRNA companies. Orna was acquired by Lilly. There are more. But look CLOSELY at what they actually do. Almost everyone does the same thing: produces circular RNA in a factory, packages it in a lipid nanoparticle (LNP), and injects it. Same recipe. Same crowded pool. Everyone is fighting for the same tricks. Circio does something completely different. Instead of producing the RNA externally and delivering it — they deliver a genetic "recipe" via a vector (AAV/DNA), and let your cell produce the circular RNA itself. Over and over again. From within. It's not a better version of what others do. It's a different way in. And in exactly that lane, Circio describes itself as the pioneer — without a known direct competitor doing exactly the same thing. Think about it. While the entire field crowds into one pool, Circio has found an entire lane they swim in alone. It's not about being the best among many. It's about being the only one in its own field. We know what we own. ♟️🧱🍷
- ·11 t sitten · MuokattuI have decided that a portrait of Erik Wiklund and Thomas Hansen shall hang in a place of honor in my home when Circio delivers big time🏆 My descendants shall know why they have it the way they are going to get it. CIRCIO ❤️❤️ maybe @bennyz also gets to hang but then I need to get a better picture of him.·9 t sittenI remember from the book about Zlatan that he had a picture of his dirty legs in the locker room after a match hanging on the wall. He was asked why he had such an ugly picture on the wall. He just replied dryly, "It is they who have paid for all this"
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 000 | - | - | ||
| 147 | - | - | ||
| 1 000 | - | - | ||
| 450 | - | - | ||
| 400 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt